LUCIUS 卢修斯 瑞司美替罗 Resmetirom非肝硬化非酒精性 脂肪性肝炎

瑞司美替罗

美国FDA批准上市产品,疗效确切
卢修斯制药(老挝)有限公司出品

Resmetirom

老挝国家食药监局批准上市
老挝国家药检所检测认证
非肝硬化非酒精性

Composition:
Each film-coated tablet contains

30 Tablets

脂肪性肝炎

Resmetirom

Indication:
LuciRes is a thyroid hormone receptor-bete (THR-

LUCÏUS

beta) agonist indicated in conjunction with diet and

PHARMACEUTICALS

exercise for the treatment of adslts with noncirthotie
nonalcoholic steatokepatitis (NASH) with moderate
to advanced liver fibrosis iconsistent with staees F2

LuciRes

Dosage and Uses
The recommended dosae of LuciRes is based on
actunl body weight. For patients weighung.

FDA批准

<100kg, the recommended dosage is 80 mg orally

Resmetirom Tablets 80mg

>100kg, the recommended dosage is 100 mg orall
*Administer LuciRes with or without food
Storage: in a dry place and store at 20C to 25C
Waraing
Keep medicine out of reach of Children.Do nol
administer LuciRes during Pregnancy and Lactatio
PLEASE SEE PACKAGE INSERT
Manufactured and Marketed by

权威认证

LUCIUS
Thongmang village, Xaythany district,
Vientiane Capical, Lios
www.lucius.la
ore sod dy reant om prescription
e plysicians only, and as directo
oy the paysicin

Rx only

口碑质量

适应症:

瑞司美替罗是一种甲状腺激素受体-β(THR-β)激动剂,与饮食和运动结
合用于治疗患有中度至晚期肝纤维化(符合F2至F3期纤维化)的非肝硬化
非酒精性脂肪性肝炎(NASH)的成年人。
推荐剂量:

1、瑞司美替罗的用量基于实际体重:
·体重<100kg,每天一次,每次80mg。
·体重≥100kg,每天一次,每次100mg。
2、如瑞司美替罗与中度CYP2C8抑制剂(例如氯吡格雷)同时使用,则需
减少剂量:
·体重<100公斤,每天一次,每次60mg。
·体重≥100公斤,每天一次,每次80mg。
3、不建议将瑞司美替罗与强效CYP2C8抑制剂(例如吉非贝齐)同时使用。